AGA Family of Websites:

Register for the third session of Biosimilars: How to Make the Switch

Take part in the June 23 session, at 8 p.m. EDT, to learn how to address patient concerns about switching to biosimilars.
Biosimilars: How to Make the Switch
Biosimilars: How to Make the Switch

In this third session of Biosimilars: How to Make the Switch, “Integration of the Patient Perspective Through Shared Decision Making and Patient Counseling,” panelists Christina Ha, MD, FACG, AGAF, Jessica Caron, MHCDS, Heidi Drescher, PA-C, and Eugen F. Yen, MD, will discuss the patient’s perspective and how to develop an effective shared-decision-making process to ensure patient understanding and acceptance of biosimilars.

If you missed the first session, “What We Know Today About Biosimilars,” or the second session, How to Achieve Seamless Adoption of Biosimilars Into Your Practice,” you can access them in AGA University.

Watch for the fourth and final webinar taking place Aug. 25, at 8 p.m. EDT, on “Case Studies Demonstrating Successful Transition to a Biosimilar. When and When Not to Switch to a Biosimilar.”

Each activity is free and certified for a maximum of 0.5 AMA PRA Category 1 Credits™, 2.0 total.

This was developed in partnership with Medical Minds and supported by an educational grant from Pfizer, Inc.

Your hub for GI education is
AGA University

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.